HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanne Leij Selected Research

Org 37663

2/2010The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanne Leij Research Topics

Disease

1Rheumatoid Arthritis
02/2010

Drug/Important Bio-Agent (IBA)

1Org 37663IBA
02/2010
1Estrogens (Estrogen)FDA Link
02/2010
1Methotrexate (Mexate)FDA LinkGeneric
02/2010
1Sulfasalazine (Azulfidine)FDA LinkGeneric
02/2010
1Gonadal Steroid Hormones (Sex Hormones)IBA
02/2010
1Estrogen Receptor alphaIBA
02/2010